About Us


About Biopulse Biotech

Biopulse Biotech, is a company founded in 2009 that operates in the life science sector. The company has a multidisciplinary approach oriented towards technological innovation and is specialized in two main sectors: biotech research oriented to the development of innovative therapeutic solutions for oncology and invention, design and production of electromedical and electrotherapeutic machinery, intended mainly, but not exclusively, for the markets of: veterinary oncology and scientific research.

New cancer therapies

The specialization of the Biopulse Biotech research group is in biotech. The founding members, Dr. Enrico Pierluigi Spugnini and Prof. Dr. Alfonso Baldi, are internationally considered among the leading experts in Electrochemotherapy and Gene Electrotherapy, as well as among the pioneers of this technique at the clinical level. The imprint given by the members is that of an integrated approach to oncology that, passing through the experimentation and innovative care of the patient in the veterinary field, includes implications on human health in the fields of innovative anti-cancer therapies, DNA vaccines, Drug Delivery methods and methods of loading molecules in vitro.

Scientific founders